Skip to main content
Menu
Main navigation
About
About
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex commodo consequat.
Why Us?
About Us
Therapeutic Experience
Research Team
Data Protection
Website Privacy Policy
Cookie Policy
Data Protection
Service Categories
Service Categories
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit laborum.
Value, Access, and HERO
Health Economics
Patient-Centered Research
Regulatory & Safety
Medical Communication
Strategic Solutions
Strategic Solutions
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit laborum.
Real-World Evidence
Careers
Careers
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit laborum.
Overview
Benefits
Career Development
Employee Stories
Sharing Knowledge
Excellent Working Atmosphere
A Reservoir of Expertise
Upholding Scientific Integrity
Commitment to Wellbeing
Developing New Skillsets
Helping Families In Need
Supportive Teams
Encouraging Senior Staff
Collaboration
Meaningful Work
Locations
Our Culture
Resource Center
Resource Center
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit laborum.
Insights
Webinars
Case Studies
Publications
Videos
Events
Search
Enter your keywords
Breadcrumb
Home
Publications
Short-term Cost-effectiveness of Recombinant Activated Factor VII In The Treatment of Intracerebral Hemorrhage
Earnshaw SR,
Wilson MR
, Joshi AV.
Short-term cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage
. Value Health. 2006 May 1;9(3):A8.
No abstract available at this time
Related Therapeutic Areas
Cardiovascular
Share on:
How Can We Help You?
How Can We Help You?
Full Name
Business Title
Email
Message
Yes, I would like to receive updates on RTI-HS news, information, and events.
